China's HNG, India's Ranbaxy End Alliance, China Drug-Making
This article was originally published in PharmAsia News
Executive Summary
China's HNG Chembio Pharmacy has lost its long-time partner, India's Ranbaxy Laboratories and its Guang-zhou Baiyunshan Pharmaceutical subsidiary
You may also be interested in...
Slow Growth And Tough Market Make China An Intriguing Puzzle For Indian Companies
MUMBAI - For large Indian drug companies, China has been a traditional and, to an extent, a dreaded rival in the business of pharmaceutical raw materials. Gargantuan Chinese factories that cropped up in the eighties almost killed scores of Indian bulk drug manufacturing units as every pricing strategy the Indian outfits could conceive of failed to beat the quotations offered by Chinese manufacturers to global brand name companies
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.